臨床醫學研究所

Medicine & Life Sciences

1. Taiwan 100%
2. Meta-Analysis 35%
3. Neoplasms 35%
4. Stroke 30%
5. Cohort Studies 28%
6. Population 28%
7. Confidence Intervals 26%
8. Therapeutics 24%
9. Chronic Renal Insufficiency 22%
10. Apoptosis 21%
11. Randomized Controlled Trials 20%
12. Systematic Reviews 20%
13. Atrial Fibrillation 18%
14. Pulmonary Veins 18%
15. Odds Ratio 18%
16. Neoplasm Metastasis 18%
17. Genes 18%
18. Arsenic 17%
19. Breast Neoplasms 17%
20. Hepatocellular Carcinoma 17%
21. Kidney 17%
22. Mortality 16%
23. Colorectal Neoplasms 15%
24. Bipolar Disorder 15%
25. Proteins 15%
26. Renal Dialysis 14%
27. Down-Regulation 14%
28. Biomarkers 14%
29. Cardiac Myocytes 13%
30. Lung 13%
31. Incidence 12%
32. Databases 12%
33. Reactive Oxygen Species 12%
34. Lung Neoplasms 12%
35. Wounds and Injuries 12%
36. Inflammation 11%
37. Serum 11%
38. Schizophrenia 11%
39. In Vitro Techniques 11%
40. Calcium 11%
41. Growth 11%
42. Autophagy 11%
43. MicroRNAs 11%
44. National Health Programs 11%
45. Survival 10%
46. Neoplastic Stem Cells 10%
47. Chronic Obstructive Pulmonary Disease 10%
48. Gene Expression 10%
49. Prostatic Neoplasms 10%
50. Up-Regulation 9%
51. Catenins 9%
52. Carcinoma 9%
53. Methylation 9%
54. Non-Small Cell Lung Carcinoma 9%
55. Drug Therapy 9%
56. Oxidative Stress 9%
57. Endothelial Cells 9%
58. Mesenchymal Stem Cells 9%
59. Sleep 9%
60. Hyperoxia 8%
61. Epithelial-Mesenchymal Transition 8%
62. ErbB Receptors 8%
63. Macrophages 8%
64. Heme Oxygenase-1 8%
65. Lipopolysaccharides 8%
66. Metabolic Syndrome 8%
67. Cell Line 8%
68. Cell Movement 8%
69. Nitric Oxide 8%
70. Retrospective Studies 8%
71. Fibrosis 8%
72. Peroxisome Proliferator-Activated Receptors 8%
73. Dialysis 8%
74. Cell Proliferation 8%
75. Case-Control Studies 8%
76. Recurrence 8%
77. Mouth Neoplasms 8%
78. Hypertension 8%
79. Pharmaceutical Preparations 7%
80. Fibroblasts 7%
81. Diabetes Mellitus 7%
82. Colonic Neoplasms 7%
83. Glioblastoma 7%
84. Safety 7%
85. Blood Pressure 7%
86. Chronic Kidney Failure 7%
87. Ovarian Neoplasms 7%
88. Liver 7%
89. Triple Negative Breast Neoplasms 7%
90. Quality of Life 7%
91. Messenger RNA 7%
92. Pneumonia 7%
93. Dementia 7%
94. Skin 7%
95. Bone and Bones 7%
96. Mutation 7%
97. Elderly 7%
98. Cardiovascular Diseases 7%
99. Depression 7%
100. Brain 6%